전체 논문 (172편 · 1/6)
-
MIF Facilitates Resistance to Androgen Deprivation Therapy by Regulating AMPD2 Expression in Prostate Cancer Cells.
-
PROSTest, a Multigene Liquid Biopsy Signature, Effectively Stratifies Patients With High PSA for Prostate Biopsy.
-
Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI.
-
Pathology of a Canine Model of Localized Prostate Carcinoma.
-
Robot-Assisted Salvage Prostatectomy: External Validation of the EAU Selection Criteria and Identification of the Optimal Candidate: A Junior ERUS/YAU Collaborative Study.
-
Integration of Primary Care Into the Follow-Up Protocol for Prostate Cancer Patients in Aragon, Spain. It Is Time to Follow Other Successful Models in the Region.
-
Association of Weight Loss and BMI on PSA Levels and Overall Survival in Veterans With Metastatic Castrate-Resistant Prostate Cancer.
-
MEIS2 Modulates Oxidative Phosphorylation and ROS Generation to Affect CD8 T Cell Antitumor Immunity in Prostate Cancer.
-
LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway.
-
Impact of Human Development Index Category on Prostate Cancer Characteristics in Asia.
-
Adapting the Bellmunt Risk Score for Prognostic Stratification in Metastatic Castration-Sensitive Prostate Cancer.
-
Robotic-Assisted Radical Prostatectomy in the Elderly Patient-A Study of Functional, Surgical, and Oncological Outcomes in an Australian Cohort.
-
Zonal-Specific Risk Stratification Integrating Magnetic Resonance Imaging and Prostate-Specific Antigen Density for Optimizing Prostate Biopsy Selection in Prostate-Specific Antigen 4-20 ng/mL Patients.
-
Genetics-Driven, Intensity-Modulated Adaptive Management of Patients With Metastatic Prostate Cancer.
-
Diagnostic Utility of 18F-DCFPyL PSMA PET/CT-Ultrasound Fusion Biopsies Across the Prostate Cancer Spectrum.
-
Are NCCN and EAU Active Surveillance Criteria Reliable in Patients With ISUP Grade-2 Intermediate-Risk Prostate Cancer? A Novel Model Integrating MRI to Predict Adverse Pathology.
-
Lessons Learned From a Mindfulness Intervention Study in Men With Newly Diagnosed Prostate Cancer.
-
The Infiltration of IL-18-Related Immune Cells and Their Bidirectional Regulatory Roles in the Pathogenesis of Prostate Cancer.
-
Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3-5 Lesions.
-
Efficacy of Early Switching From Docetaxel to Cabazitaxel in Castration-Resistant Prostate Cancer.
-
Utility of the PROSTest, a Novel Blood-Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease.
-
The Germline HSD3B1 Variant Is Associated With Response to Androgen Deprivation Therapy and Abiraterone but not With Response to Enzalutamide in Chinese Prostate Cancer Patients.
-
Towards Precision Oncology: A New Predictive Machine Learning Model for Early Progression to Castration Resistant Prostate Cancer.
-
Spatial Characteristics of Intraductal Carcinoma of the Prostate.
-
The Impact of Early Modification of Upfront Androgen Receptor Signaling Inhibitors on Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer.
-
Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer.
-
Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial.
-
Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways.
-
Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5 T MR Guided Adaptive Technique.
-
Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer.